DK0680470T3 - - Google Patents

Info

Publication number
DK0680470T3
DK0680470T3 DK94906446.3T DK94906446T DK0680470T3 DK 0680470 T3 DK0680470 T3 DK 0680470T3 DK 94906446 T DK94906446 T DK 94906446T DK 0680470 T3 DK0680470 T3 DK 0680470T3
Authority
DK
Denmark
Prior art keywords
pct
sec
date
tumors
pub
Prior art date
Application number
DK94906446.3T
Other languages
Danish (da)
English (en)
Inventor
Jules Freedman
Sai P Sunkara
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0680470T3 publication Critical patent/DK0680470T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK94906446.3T 1993-01-21 1993-12-17 DK0680470T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US656993A 1993-01-21 1993-01-21

Publications (1)

Publication Number Publication Date
DK0680470T3 true DK0680470T3 (enExample) 1997-04-28

Family

ID=21721516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94906446.3T DK0680470T3 (enExample) 1993-01-21 1993-12-17

Country Status (20)

Country Link
US (1) US5648365A (enExample)
EP (1) EP0680470B1 (enExample)
JP (1) JP3398748B2 (enExample)
KR (1) KR100377280B1 (enExample)
AT (1) ATE150748T1 (enExample)
AU (1) AU679723B2 (enExample)
CA (1) CA2152794C (enExample)
DE (1) DE69309310T2 (enExample)
DK (1) DK0680470T3 (enExample)
ES (1) ES2102830T3 (enExample)
FI (1) FI112474B (enExample)
GR (1) GR3023188T3 (enExample)
HU (1) HUT72078A (enExample)
IL (1) IL108369A (enExample)
MX (1) MX9400563A (enExample)
NO (1) NO305166B1 (enExample)
NZ (1) NZ261414A (enExample)
TW (1) TW243445B (enExample)
WO (1) WO1994017040A1 (enExample)
ZA (1) ZA94317B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129144C (en) * 1992-02-06 1999-07-13 Jules Freedman Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives
AU6366000A (en) * 1999-07-23 2001-02-13 Colorado State University Research Foundation Multidrug resistance pump inhibitors and uses thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
CA2465886A1 (en) * 2001-11-07 2003-05-15 Kathleen S. Crowley Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
KR100656490B1 (ko) 2001-11-26 2006-12-12 삼성에스디아이 주식회사 풀칼라 유기전계 발광표시소자 및 그의 제조방법
US8153184B2 (en) * 2001-11-26 2012-04-10 Samsung Mobile Display Co., Ltd. Organic EL display device and method of manufacturing the same
ES2831028T3 (es) 2013-02-08 2021-06-07 Gen Mills Inc Productos alimenticios reducidos en sodio
CN110372571B (zh) * 2018-04-12 2022-11-15 中国科学院大连化学物理研究所 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1049377B (de) * 1952-04-03 1959-01-29 Abbott Laboratories, North Chicago, 111. (V. St. A.) Verfahren zur Herstellung von substituierten Vinylpiperidinen
US2898339A (en) * 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US4035372A (en) * 1976-08-13 1977-07-12 G. D. Searle & Co. 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines
EP0228893A3 (en) * 1985-12-20 1990-01-03 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US4990511A (en) * 1988-08-03 1991-02-05 Takeda Chemical Industries, Ltd. Amide compounds, their production and use
KR920702620A (ko) * 1989-06-19 1992-10-06 엠. 피. 잭슨 암치료에 유용하며 항히스타민성 특성을 갖는 약물
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
EP0467435A3 (en) * 1990-07-19 1992-04-01 Akzo N.V. Benzhydryl derivatives having calmodulin inhibitor properties
DE69128820T2 (de) * 1990-08-14 1998-06-10 Hoechst Marion Roussel Inc Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon
CA2129144C (en) * 1992-02-06 1999-07-13 Jules Freedman Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives

Also Published As

Publication number Publication date
NZ261414A (en) 1997-06-24
JPH08505870A (ja) 1996-06-25
TW243445B (enExample) 1995-03-21
NO952885L (no) 1995-09-20
AU679723B2 (en) 1997-07-10
HU9502195D0 (en) 1995-09-28
DE69309310D1 (de) 1997-04-30
EP0680470B1 (en) 1997-03-26
ZA94317B (en) 1994-08-18
ES2102830T3 (es) 1997-08-01
JP3398748B2 (ja) 2003-04-21
NO305166B1 (no) 1999-04-12
AU6014894A (en) 1994-08-15
KR960700230A (ko) 1996-01-19
FI953506A0 (fi) 1995-07-20
GR3023188T3 (en) 1997-07-30
FI953506L (fi) 1995-07-20
HUT72078A (en) 1996-03-28
IL108369A (en) 1999-08-17
NO952885D0 (no) 1995-07-20
US5648365A (en) 1997-07-15
DE69309310T2 (de) 1997-11-06
MX9400563A (es) 1994-07-29
EP0680470A1 (en) 1995-11-08
WO1994017040A1 (en) 1994-08-04
ATE150748T1 (de) 1997-04-15
KR100377280B1 (ko) 2003-07-18
FI112474B (fi) 2003-12-15
CA2152794A1 (en) 1994-08-04
CA2152794C (en) 1999-04-06
IL108369A0 (en) 1994-04-12

Similar Documents

Publication Publication Date Title
AU5454894A (en) Pyrazoles having CRF antagonist activity
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
SG55184A1 (en) New imidazopyridines
FI954579A0 (fi) Uusia pednisolonijohdannaisia
DK0680470T3 (enExample)
AU2797695A (en) Thiazolidine derivatives, their preparation and drugs containing same
DE69428546D1 (en) 3-acylaminobenzazepine
IL104599A (en) Pharmaceutical compositions for reversal of multi-drug resistance comprising tetraarylethylenes
TW251283B (enExample)
ATE149159T1 (de) Heteroarylmethylbenzole-aromatasehemmer
AU3809095A (en) 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
ATE170850T1 (de) Aminoalkylsubstituierte 5-mercaptothiazole, ihre herstellung und verwendung